Guardian Financial Statements From 2010 to 2026

GRDN Stock   30.94  0.03  0.1%   
Guardian Pharmacy's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Guardian Pharmacy's valuation are provided below:
Gross Profit
274.3 M
Profit Margin
0.029
Market Capitalization
B
Enterprise Value Revenue
1.4095
Revenue
1.4 B
We have found one hundred twenty available fundamental trends for Guardian Pharmacy, which can be analyzed and compared to other ratios and to its competitors. Self-guided Investors are advised to confirm Guardian Pharmacy's regular fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road.

Guardian Pharmacy Total Revenue

944.46 Million

Check Guardian Pharmacy financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Guardian Pharmacy's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.4 M, Interest Expense of 2.5 M or Selling And Marketing Expenses of 3 M, as well as many indicators such as Price To Sales Ratio of 1.35, Dividend Yield of 0.022 or PTB Ratio of 9.62. Guardian financial statements analysis is a perfect complement when working with Guardian Pharmacy Valuation or Volatility modules.
  
Build AI portfolio with Guardian Stock
Check out the analysis of Guardian Pharmacy Correlation against competitors.

Guardian Pharmacy Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets264 M368.9 M221.6 M
Slightly volatile
Short and Long Term Debt Total60.4 M42.9 M49.2 M
Slightly volatile
Other Current Liabilities25.4 M35.7 M19.1 M
Slightly volatile
Total Current Liabilities117.5 M165.7 M91.3 M
Slightly volatile
Total Stockholder Equity172.3 M164.1 M56.3 M
Slightly volatile
Property Plant And Equipment Net60.4 M90.8 M44.7 M
Slightly volatile
Net Debt55.7 M37.6 M45.8 M
Slightly volatile
Accounts Payable76.5 M117.8 M62.4 M
Slightly volatile
Cash4.7 M5.4 M3.4 M
Slightly volatile
Non Current Assets Total141.7 M194.1 M120.1 M
Slightly volatile
Non Currrent Assets Other6.8 M6.5 MM
Slightly volatile
Cash And Short Term Investments4.7 M5.4 M3.4 M
Slightly volatile
Net Receivables69.9 M111.7 M59.3 M
Slightly volatile
Good Will60.1 M79.7 M53.2 M
Slightly volatile
Common Stock Shares Outstanding67.1 M71.3 M61.9 M
Slightly volatile
Liabilities And Stockholders Equity249.7 M368.9 M199.4 M
Slightly volatile
Non Current Liabilities Total45.9 M24 M50.6 M
Very volatile
Inventory38.1 M46.6 M32.2 M
Slightly volatile
Other Current Assets9.6 M11.1 M6.6 M
Slightly volatile
Total Liabilities180.5 M196.5 M143.3 M
Slightly volatile
Total Current Assets122.4 M174.8 M101.5 M
Slightly volatile
Short Term Debt15.6 M12.2 M9.8 M
Slightly volatile
Intangible Assets13.9 M13.4 M20 M
Slightly volatile
Common Stock53.9 K56.7 K27.7 M
Slightly volatile
Long Term Debt19.9 M17.1 M27.2 M
Slightly volatile
Capital Lease Obligations28.4 M34.7 M25.7 M
Slightly volatile
Net Invested Capital88.9 M164.1 M81.5 M
Slightly volatile
Property Plant And Equipment Gross138.7 M180.5 M114.3 M
Slightly volatile
Short and Long Term Debt7.8 M14.9 M5.9 M
Slightly volatile
Non Current Liabilities Other3.7 M3.9 M6.3 M
Slightly volatile
Retained Earnings13.7 M15.4 M16.8 M
Slightly volatile
Capital Stock50.4 K56.7 K61.9 K
Slightly volatile

Guardian Pharmacy Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization18.4 M22.7 M15.5 M
Slightly volatile
Interest Expense2.5 M3.8 M2.2 M
Slightly volatile
Selling And Marketing ExpensesM3.2 M74.1 M
Slightly volatile
Total Revenue944.5 M1.4 B774.7 M
Slightly volatile
Gross Profit190.7 M281 M157 M
Slightly volatile
Other Operating Expenses920.5 M1.5 B756.4 M
Slightly volatile
Cost Of Revenue753.8 M1.1 B617.7 M
Slightly volatile
Total Operating Expenses371.1 M353.4 M150.7 M
Slightly volatile
Selling General Administrative361.5 M344.3 M136.3 M
Slightly volatile
Reconciled Depreciation19.4 M22.7 M17.8 M
Slightly volatile
Income Tax Expense3.6 M4.1 M4.5 M
Slightly volatile

Guardian Pharmacy Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow46.9 M47.8 M39 M
Slightly volatile
Begin Period Cash Flow821.6 K864.8 K1.8 M
Slightly volatile
Depreciation18.4 M22.7 M15.5 M
Slightly volatile
Other Non Cash Items4.9 M8.2 MM
Slightly volatile
Dividends Paid30.7 M41.1 M28.9 M
Slightly volatile
Capital Expenditures14.1 M18.8 M11.9 M
Slightly volatile
Total Cash From Operating Activities61 M66.7 M50.9 M
Slightly volatile
End Period Cash Flow4.7 M5.4 M3.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.351.181.4173
Slightly volatile
Dividend Yield0.0220.02560.0277
Pretty Stable
PTB Ratio9.6210.1325.5644
Slightly volatile
Days Sales Outstanding21.5425.9827.5196
Slightly volatile
Book Value Per Share2.292.181.2998
Slightly volatile
Free Cash Flow Yield0.03390.02980.0375
Pretty Stable
Operating Cash Flow Per Share0.730.840.8045
Slightly volatile
Average Payables52.2 M64.2 M61.1 M
Slightly volatile
Capex To Depreciation0.620.750.7546
Very volatile
PB Ratio9.6210.1325.5644
Slightly volatile
EV To Sales1.421.211.4811
Slightly volatile
Free Cash Flow Per Share0.560.60.6163
Slightly volatile
Inventory Turnover15.6921.8418.441
Slightly volatile
Days Of Inventory On Hand20.7917.319.933
Slightly volatile
Payables Turnover10.9311.0510.1125
Pretty Stable
Capex To Revenue0.01670.01530.016
Slightly volatile
Cash Per Share0.05620.06760.0536
Pretty Stable
POCF Ratio20.4724.9320.8219
Slightly volatile
Capex To Operating Cash Flow0.180.250.2295
Very volatile
PFCF Ratio19.6927.1826.4962
Slightly volatile
Days Payables Outstanding29.4534.1936.0035
Slightly volatile
EV To Operating Cash Flow21.4825.5721.7455
Slightly volatile
EV To Free Cash Flow28.4135.6428.5899
Pretty Stable
Intangibles To Total Assets0.340.30.3499
Slightly volatile
Current Ratio1.171.211.1608
Slightly volatile
Receivables Turnover15.014.5413.2825
Slightly volatile
Shareholders Equity Per Share2.172.070.847
Slightly volatile
Debt To Equity0.290.31.2763
Pretty Stable
Capex Per Share0.170.240.1881
Slightly volatile
Revenue Per Share11.2517.8312.1424
Slightly volatile
Interest Debt Per Share0.750.590.8178
Pretty Stable
Debt To Assets0.260.130.2333
Slightly volatile
Graham Number1.681.821.8896
Slightly volatile
Short Term Coverage Ratios11.36.2812.7651
Slightly volatile
Operating Cycle50.4150.4948.352
Slightly volatile
Price Book Value Ratio9.6210.1325.5644
Slightly volatile
Days Of Payables Outstanding29.4534.1936.0035
Slightly volatile
Price To Operating Cash Flows Ratio20.4724.9320.8219
Slightly volatile
Price To Free Cash Flows Ratio19.6927.1826.4962
Slightly volatile
Ebt Per Ebit0.750.950.9114
Pretty Stable
Company Equity Multiplier2.462.595.4216
Pretty Stable
Long Term Debt To Capitalization0.50.460.4813
Slightly volatile
Total Debt To Capitalization0.230.240.5265
Slightly volatile
Debt Equity Ratio0.290.31.2763
Pretty Stable
Quick Ratio0.790.890.7829
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.681.281.345
Slightly volatile
Net Income Per E B T0.61.180.7093
Slightly volatile
Cash Ratio0.04550.03720.0382
Very volatile
Cash Conversion Cycle9.926.8111.1409
Slightly volatile
Operating Cash Flow Sales Ratio0.07340.05430.0692
Slightly volatile
Days Of Inventory Outstanding20.7917.319.933
Slightly volatile
Days Of Sales Outstanding21.5425.9827.5196
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.850.830.7769
Pretty Stable
Cash Flow Coverage Ratios0.831.41.03
Pretty Stable
Price To Book Ratio9.6210.1325.5644
Slightly volatile
Fixed Asset Turnover17.9917.8918.9398
Slightly volatile
Capital Expenditure Coverage Ratio5.054.074.4806
Very volatile
Price Cash Flow Ratio20.4724.9320.8219
Slightly volatile
Debt Ratio0.260.130.2333
Slightly volatile
Cash Flow To Debt Ratio0.831.41.03
Pretty Stable
Price Sales Ratio1.351.181.4173
Slightly volatile
Asset Turnover2.843.453.3845
Pretty Stable
Gross Profit Margin0.220.230.2062
Slightly volatile
Price Fair Value9.6210.1325.5644
Slightly volatile

Guardian Pharmacy Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market CapB1.1 B1.2 B
Slightly volatile
Enterprise ValueB1.2 B1.3 B
Slightly volatile

Guardian Fundamental Market Drivers

Forward Price Earnings30.03
Cash And Short Term Investments4.7 M

About Guardian Pharmacy Financial Statements

Guardian Pharmacy investors utilize fundamental indicators, such as revenue or net income, to predict how Guardian Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue1.4 B944.5 M
Cost Of Revenue1.1 B753.8 M
Stock Based Compensation To Revenue 0.10  0.10 
Capex To Revenue 0.02  0.02 
Revenue Per Share 17.83  11.25 
Ebit Per Revenue(0.06)(0.06)

Pair Trading with Guardian Pharmacy

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guardian Pharmacy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardian Pharmacy will appreciate offsetting losses from the drop in the long position's value.

Moving together with Guardian Stock

  0.65DG Dollar GeneralPairCorr

Moving against Guardian Stock

  0.81GO Grocery Outlet HoldingPairCorr
  0.79HITI High TidePairCorr
  0.76SYY SyscoPairCorr
  0.76HITI High TidePairCorr
  0.75SFM Sprouts Farmers MarketPairCorr
The ability to find closely correlated positions to Guardian Pharmacy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guardian Pharmacy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guardian Pharmacy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guardian Pharmacy Services to buy it.
The correlation of Guardian Pharmacy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guardian Pharmacy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guardian Pharmacy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guardian Pharmacy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Guardian Pharmacy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Guardian Pharmacy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Guardian Pharmacy Services Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Guardian Pharmacy Services Stock:
Check out the analysis of Guardian Pharmacy Correlation against competitors.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardian Pharmacy. If investors know Guardian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardian Pharmacy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.68
Revenue Per Share
22.163
Quarterly Revenue Growth
0.2
Return On Assets
0.1055
Return On Equity
0.24
The market value of Guardian Pharmacy is measured differently than its book value, which is the value of Guardian that is recorded on the company's balance sheet. Investors also form their own opinion of Guardian Pharmacy's value that differs from its market value or its book value, called intrinsic value, which is Guardian Pharmacy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardian Pharmacy's market value can be influenced by many factors that don't directly affect Guardian Pharmacy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardian Pharmacy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.